Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide

Journal of Endocrinological Investigation

Volumn 21, Issue 11, 1998, Pages 775-778

  Iglesias, P ^a,c   Diez J J ^b  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c C/Maria Seiilla Diago   (Spain)

Author keywords

Octreotide; Pituitary adenoma; Secondary hyperthyroidism; Thyrotrophin; Tumoral volume

Indexed keywords

HYPOTHALAMUS RELEASE INHIBITING FACTOR; LIOTHYRONINE; OCTREOTIDE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; FREE THYROXINE INDEX; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE TREATMENT; SUBCUTANEOUS DRUG ADMINISTRATION; THYROTROPIN BLOOD LEVEL; TRANSSPHENOIDAL SURGERY;

EID: 0032421542     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348045     Document Type: Article

References (12)

1. Beck-Peccoz P., Brucker-Davis F., Persani L., Smallridge R.C., Weintraub B.D. Thyrotropin-secreting pituitary tumors. Endocr. Rev. 17: 610, 1996.
2. Greenman Y., Melmed S. Thyrotropin-secreting pituitary tumors. In: Melmed S. (Ed.), The Pituitary. Blackwell Science, Massachusetts, 1995, p. 546.
3. Gesundheit N., Petrick P.A., Nissim M., Dahlberg P.A., Doppman J.L., Emerson C.L., Braverman L.E., Oldfield E.H., Weintraub B.D. Thyrotropin-secreting pituitary adenomas: Clinical and biochemical heterogeneity. Ann. Intern. Med. 111: 827, 1989.
4. Chanson P., Weintraub B., Harris A.G. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. Ann. Intern. Med. 119: 236, 1993.
5. Gancel A., Vuillermet P., Legrand A., Catus F., Thomas F., Kuhn J.M. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin. Endocrinol. 40: 421, 1994.
6. Wynne A.G., Gharib H., Scheithauer B.W., Davis D.H., Freeman S.L., Horvath E. Hyperthryoidism due to inappropriate secretion of thyrotropin in 10 patients. Am. J. Med. 92: 15, 1992.
7. Smallridge R.C. Thyrotropin-secreting pituitary tumors. Endocrinol. Metab. Clin. North Am. 16: 765, 1987.
8. Weintraub B.D., Gershengorn M.C., Kourides I.A., Fein H. Inappropriate secretion of thyroid-stimulating hormone. Ann. Intern. Med. 95: 339, 1981.
9. Katz M.S., Gregerman R.I., Horvath E., Kovacks K., Ezrin C. Thyrotropin cell adenoma of the human pituitary gland associated with primary hypothyroidism: clinical and morphological features. Acta Endocrinol. 95: 41, 1980.
10. Losa M., Giovanelli M., Persani L., Mortini P., Faglia G., Beck-Peccoz P. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 81: 3086, 1996.
11. McCutcheon I.E., Weintraub B.D., Oldfield E.H. Surgical treatment of thyrotropin secreting adenomas. J. Neurosurg. 73: 674, 1990.
12. Guillausseau P.J., Chanson P.H., Timsit J., Warnet A., Lajeunie E., Duet M., Lubetski J. Visual improvement with SMS 201-995 in a patient with a thyrotropin-secreting pituitary adenoma. N. Engl. J. Med. 317: 53, 1987.